Core Laboratories (CLB) Gains from Sales and Divestitures (2023 - 2025)

Core Laboratories has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $463244.0 in Q4 2025.

• For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 80.44% year-over-year to $463244.0; the trailing twelve-month figure through Dec 2025 stood at $463244.0 (up 80.44% YoY), and the FY2025 full-year result was $463244.0, up 80.44% from the prior year.
• Gains from Sales and Divestitures for Q4 2025 stood at $463244.0, up from $256724.0 in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $463244.0 in Q4 2025, with the low at $256724.0 in Q4 2024.
• Historically, Gains from Sales and Divestitures has averaged $352270.7 across 3 years, with a median of $336844.0 in 2023.
• Annual changes were most pronounced in 2024 — Gains from Sales and Divestitures fell 23.79% — and 2025, when it soared 80.44%.
• Core Laboratories' Gains from Sales and Divestitures stood at $336844.0 in 2023, then slipped by 23.79% to $256724.0 in 2024, then soared by 80.44% to $463244.0 in 2025.
• The last three Gains from Sales and Divestitures figures came in at $463244.0 (Q4 2025), $256724.0 (Q4 2024), and $336844.0 (Q4 2023), per Business Quant data.